Possible role of DNA topoisomerase II on transcription of the homeobox gene Hox-2.1 in F9 embryonal carcinoma cells.
AUTOR(ES)
Ura, K
RESUMO
The Hox-2.1 gene is one of homeobox-containing genes located in the Hox-2 cluster on mouse chromosome 11. In this study, we have examined transcription of the Hox-2.1 gene during differentiation of F9 embryonal carcinoma cells induced by treatment with retinoic acid. The level of Hox-2.1 mRNA increases rapidly after induction of differentiation and then falls. Nuclear run-on experiments demonstrate that the rate of transcription for the Hox-2.1 gene also increases upon differentiation. Treatment of F9 cells with a DNA topoisomerase II inhibitor etoposide (VP-16) during differentiation blocks the accumulation of Hox-2.1 mRNA. Nuclear run-on analyses reveal that etoposide inhibits transcription of the Hox-2.1 gene during F9 cell differentiation. Measurements of the level of Hox-2.1 mRNA after blocking transcription by actinomycin D show that etoposide does not affect stability of the mRNA. These observations indicate that DNA topoisomerase II is involved in the control of Hox-2.1 gene transcription.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=329094Documentos Relacionados
- Differential expression of the homeobox gene Hox-1.3 in F9 embryonal carcinoma cells.
- Retroviral vector gene expression in F9 embryonal carcinoma cells.
- Multicomponent differentiation-regulated transcription factors in F9 embryonal carcinoma stem cells.
- SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells.
- Control of beta-interferon expression in murine embryonal carcinoma F9 cells.
